Pharma Excipient Suppliers for Polymyxin B Sulfate

01

EUROAPI

France

NextGen Biomed

Attending

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Dosage Form : Tablet

Grade : Oral

Brand Name : Calcium Lactate-Glycerol Ad...

Application : Fillers, Diluents & Binders

Excipient Details : Calcium lactate-glycerol adduct is used both as a stabilizer and a binder in tablet formulations.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Calcium Lactate, Glycerol Excipient

Dosage Form : Tablet

Grade : Oral

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Ingredient(s) : Calcium Lactate, Glycerol Excipient

Dosage Form : Tablet

Category : Fillers, Diluents & Binders

Brand : CALCIUM LACTATE-GLYCEROL ADDUCT

Applications : Calcium lactate-glycerol adduct is used both as a stabilizer and a binder in tablet formulations.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

02

Anhui Sunhere Pharmaceutical Excipients ...

HYPROMELLOSE

PharmScience R&D

Not Confirmed

Not Confirmed

Looking for Fillers, Diluents & Binders? Find Fillers, Diluents & Binders Agents used in Polymyxin B Sulfate to address drug delivery challenges on PharmaCompass.

Polymyxin B Sulfate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

34 API Suppliers

13 USDMF

6 CEP/COS

2 JDMF

1 EU WC

2 KDMF

20 NDC API

23 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

7 Drugs in Development

FINISHED DOSAGE FORMULATIONS

144 FDF Dossiers

95 FDA Orange Book

7 Europe

19 Canada

7 South Africa

16 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM

OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - 0.5%;EQ 3.5MG BASE/GM;10,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

OINTMENT;OPHTHALMIC - EQ 400 UNITS/GM;EQ 3.5MG BASE/GM;EQ 10,000 UNITS/GM

SOLUTION/DROPS;OPHTHALMIC - 10,000 UNITS/ML;EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 SPI Pharma

2 Seqens

2 DKSH

8 Nanjing Well Pharmaceutical

1 Pfanstiehl

1 ACG Worldwide

17 Actylis

2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

24 BASF

10 Corel Pharma Chem

3 Finar

9 Gangwal Chemicals

4 Ideal Cures Pvt Ltd

19 Kerry

3 Kima Chemical

6 Lonza Capsugel

4 Microlex e.U

2 Nanjing Bold Chemical

2 Nippon Fine Chemical

2 Nomisma Healthcare

1 Novo Excipients

1 Pluviaendo

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

5 Roquette

17 Seppic

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Sigachi Industries

2 The Dow Chemical Company

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Coating Systems & Additives

37 Topical

33 Solubilizers

23 Parenteral

20 Controlled & Modified Release

19 Thickeners and Stabilizers

17 Emulsifying Agents

15 Film Formers & Plasticizers

10 Co-Processed Excipients

10 Surfactant & Foaming Agents

8 Fillers, Diluents & Binders

8 Direct Compression

7 Granulation

5 Empty Capsules

5 API Stability Enhancers

5 Lubricants & Glidants

OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CREAM;TOPICAL - 0.5%;EQ 3.5MG BASE/GM;10,000 UNITS/GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION/DROPS;OPHTHALMIC - 10,000 UNITS/ML;EQ 1MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons